12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • ProPhase Labs PRPH shares increased by 30.62% to $8.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $124.1 million. As per the news, the Q4 earnings report came out today.
  • Ocugen OCGN shares moved upwards by 13.92% to $7.69. The company's market cap stands at $1.4 billion.
  • Surface Oncology SURF shares rose 13.24% to $8.21. The company's market cap stands at $342.5 million.
  • Delcath Systems DCTH shares rose 10.56% to $18.0. The company's market cap stands at $112.4 million. As per the press release, Q4 earnings came out today.
  • Equillium EQ stock increased by 10.43% to $7.3. The market value of their outstanding shares is at $211.9 million.
  • Windtree Therapeutics WINT shares moved upwards by 9.34% to $2.34. The company's market cap stands at $39.8 million. As per the press release, Q4 earnings came out 2 days ago.

 

 

Losers

 

  • 9 Meters Biopharma NMTR shares decreased by 19.12% to $1.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $237.6 million.
  • Celsion CLSN shares declined by 9.82% to $1.47. The market value of their outstanding shares is at $110.2 million.
  • Humanigen HGEN shares fell 7.27% to $20.1. The market value of their outstanding shares is at $1.0 billion.
  • PolarityTE PTE stock decreased by 5.79% to $1.14. The market value of their outstanding shares is at $76.1 million. As per the news, the Q4 earnings report came out yesterday.
  • INVO Bioscience INVO stock decreased by 5.67% to $4.66. The market value of their outstanding shares is at $44.5 million. The company's, Q4 earnings came out yesterday.
  • Checkpoint Therapeutics CKPT stock fell 5.23% to $2.9. The market value of their outstanding shares is at $218.1 million.

 

 

Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...